DTIL — Precision Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Precision Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	181	89.8	144	190	117
Net Total Accounts Receivable
Net Total Receivables	0.965	10	0.488	0.72	12.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	194	106	162	199	136
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39.6	41.5	29.3	23.2	14.6
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	235	150	211	238	160
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	26.9	42.8	36	59.7	50
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	96.9	106	120	178	141
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	138	44.4	91.2	60.4	18.9
Total Liabilities & Shareholders' Equity	235	150	211	238	160
Total Common Shares Outstanding